Plus LibraryBy pinki@katapult.biz / February 13, 2025 Speciality — Amyotrophic Lateral Sclerosis (ALS) Biomarkers Biosimilars Bladder Blood Bone Brain Breast Cancer Central Nervous System (CNS) Clinical Trials Colon Colorectal Diversity, Equity & Inclusion Featured Content Gastrointestinal Genitourinary Genomic Geriatric Gynecology Head and Neck Hematologic Hematologic Maglinencies Hematology Immunotherapy Interventional Radiology Kidney Leukemia Liquid Biopsy Liver Lung Lymphoma Malignencies Melanoma Myelodysplastic Syndrome Myeloma Neuroendocrine Novel Oral & Maxillofacial Surgery Ovarian Pancreas Pancreatic Pharmacological Prostate Radiation Radiology Renal Sarcoma Skin Solid Tumor Supportive & Palliative Care Survivorship Telemedicine Thoracic Thrombosis Thymic Thyroid Urothelial Author / Speaker Title of Presentation Type of Media — Video Document Audio Event 2024 Event — 2024 California Cancer Consortium Conference (CCC) 2024 MLS Cleveland 2024 MLS Nashville 2024 MLS New Orleans 2024 MLS Seattle 2024 New Orleans Summer Cancer Meeting (NOSCM) 2024 PRIMO 2024 SPS Puerto Rico 2024 SPS Seattle 2024 SPECTRUM 2024 Sylvester APP Oncology Symposium 2024 WCS 2024 MaTOS Lungs 2025 PRIMO Clear Displaying 201 - 225 of 2,875 « 1 … 7 8 9 10 11 … 115 » Changing Delivery of Chemotherapy for Breast Cancer: The Broad Impact of Antibody Drug Conjugates Hope Rugo, MD, FASCO View Video The Entire Sepctrum of Her-2 Management in Breast Cancer Disease: All Clinical Settings Hope S Rugo - MD View Video Updates in the Management of HER-2 Positive Breast Cancer Hope S Rugo, MD View Video Updates in the Management of HER2 Positive Breast Cancer Hope S. Rugo, MD View PDF The Entire Sepctrum of Her-2Management in Breast Cancer Disease - All Clinical Settings Hope S. Rugo, MD View PDF Targeted Therapy for Metastatic HR+/HER2- Breast Cancer: CDK4/6 and PI3K Hope S. Rugo, MD View PDF Triple Negative Breast Cancer: Optimal Neoadjuvant Therapy and New Directions Hope S. Rugo, MD View PDF Targeted Therapy for Metastatic HR+/HER2- Breast Cancer: CDK4/6 and PI3K Hope S. Rugo, MD View Video Antibody Drug Conjugates: New Agents and Optimal Sequencing Hope S. Rugo, MD, FASCO View PDF Antibody Drug Conjugates: New Agents and Optimal Sequencing Hope S. Rugo, MD, FASCO View Video Breast Cancer Update in Hormone Sensitive Breast Cancer Ingrid A. Mayer, MD, MSCI View PDF Breast Cancer Update in Hormone Sensitive Breast Cancer Ingrid A. Mayer, MD, MSCI View Video Breast Cancer Update in Hormone Sensitive Breast Cancer Ingrid Mayer, MD View PDF Breast Cancer Update in Hormone Sensitive Breast Cancer Ingrid Mayer, MD View Video HER2-Driven Breast Cancer: Current Status and Next Generation Therapeutics Jane Lowe Meisel, MD View PDF HER2-Driven Breast Cancer: Current Status and Next Generation Therapeutics Jane Lowe Meisel, MD View Video ADC in Breast Cancer Management Jane Lowe Meisel, MD View PDF ADC in Breast Cancer Management Jane Lowe Meisel, MD View Video The Management of HER2+ Breast Cancer: A Rapidly Changing Frontier Jane Meisel, MD View PDF Advances in HER2 Positive Metastatic Breast Cancer Janice Lu, MD, PhD View Video Radiation Theraphy and Genomic Interactions in Breast Cancer Patients Javier F. Torres-Roca, MD View PDF Triple Negative Breast Cancer Jennifer R. Diamond, MD View PDF Triple Negative Breast Cancer Jennifer R. Diamond, MD View Video Advanced Breast Cancer: State of the Art Joanne Mortimer, MD, FACP, FASCO View PDF Advanced Breast Cancer: State of the Art Joanne Mortimer, MD, FACP, FASCO View Video
